2007
DOI: 10.1038/sj.onc.1210202
|View full text |Cite
|
Sign up to set email alerts
|

The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

5
237
0
14

Year Published

2007
2007
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 265 publications
(256 citation statements)
references
References 77 publications
(88 reference statements)
5
237
0
14
Order By: Relevance
“…IRS-4 has previously been shown to increase proliferation in non-stimulated cells (Qu et al, 1999). The deregulation of PI3 kinase and Akt signalling plays a major part in cellular transformation and cancer progression (Dillon et al, 2007). Although mRNA is limited to only a few normal human cell types, increased levels have been detected in some carcinoma cells, including HEP-2 and A431 cells, whereas IRS-4 protein has been found to be endogenously expressed in A431 and MDA-MB 231 tumour cells (Qiu et al, 2005), indicating that the deregulation of this gene in the absence of Ad5E1A might play an important role in tumourigenesis.…”
Section: Discussionmentioning
confidence: 99%
“…IRS-4 has previously been shown to increase proliferation in non-stimulated cells (Qu et al, 1999). The deregulation of PI3 kinase and Akt signalling plays a major part in cellular transformation and cancer progression (Dillon et al, 2007). Although mRNA is limited to only a few normal human cell types, increased levels have been detected in some carcinoma cells, including HEP-2 and A431 cells, whereas IRS-4 protein has been found to be endogenously expressed in A431 and MDA-MB 231 tumour cells (Qiu et al, 2005), indicating that the deregulation of this gene in the absence of Ad5E1A might play an important role in tumourigenesis.…”
Section: Discussionmentioning
confidence: 99%
“…22 Membrane recruitment and binding to PtdIns (3,4,5)P3 causes conformational changes in Akt, resulting in exposure of its phoshorylation sites T308 and S473 which are then phosphorylated by phosphoinositide dependent kinase (PDK) and mammalian target of rapamycin (mTOR)/rictor, respectively. 23,24 Thus, the activated (phosphorylated) Akt stays mostly in the cytoplasm. However, under certain conditions it may also be transferred into the nucleus.…”
Section: Introductionmentioning
confidence: 99%
“…10 This has made Akt a major target for cancer drug discovery. [12][13][14][15] There are three mammalian Akt isoforms that may play distinct but also overlapping roles in development, normal physiology and tumorigenesis. For example, in mice, loss of Akt1 function results in smaller body size and significant growth defects.…”
Section: Introductionmentioning
confidence: 99%